Edinburgh Research Explorer

CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: implication for CD40 ligand antibody therapy

Research output: Contribution to journalArticle

Standard

CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice : implication for CD40 ligand antibody therapy. / Sharp, Colin; Thompson, Claire; Samy, Eileen T; Noelle, Randolph; Tung, Kenneth S K.

In: Journal of Immunology, Vol. 170, No. 4, 2003, p. 1667-74.

Research output: Contribution to journalArticle

Harvard

Sharp, C, Thompson, C, Samy, ET, Noelle, R & Tung, KSK 2003, 'CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: implication for CD40 ligand antibody therapy', Journal of Immunology, vol. 170, no. 4, pp. 1667-74.

APA

Sharp, C., Thompson, C., Samy, E. T., Noelle, R., & Tung, K. S. K. (2003). CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: implication for CD40 ligand antibody therapy. Journal of Immunology, 170(4), 1667-74.

Vancouver

Sharp C, Thompson C, Samy ET, Noelle R, Tung KSK. CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: implication for CD40 ligand antibody therapy. Journal of Immunology. 2003;170(4):1667-74.

Author

Sharp, Colin ; Thompson, Claire ; Samy, Eileen T ; Noelle, Randolph ; Tung, Kenneth S K. / CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice : implication for CD40 ligand antibody therapy. In: Journal of Immunology. 2003 ; Vol. 170, No. 4. pp. 1667-74.